Literature DB >> 24302766

Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed-Sternberg cells.

Benjamin Rengstl1, Sebastian Newrzela, Tim Heinrich, Christian Weiser, Frederic B Thalheimer, Frederike Schmid, Kathrin Warner, Sylvia Hartmann, Timm Schroeder, Ralf Küppers, Michael A Rieger, Martin-Leo Hansmann.   

Abstract

Multinucleated Reed-Sternberg (RS) cells are pathognomonic for classical Hodgkin lymphoma (HL), and their presence is essential for diagnosis. How these giant tumor cells develop is controversial, however. It has been postulated that RS cells arise from mononucleated Hodgkin cells via endomitosis. Conversely, continuous single-cell tracking of HL cell lines by long-term time-lapse microscopy has identified cell fusion as the main route of RS cell formation. In contrast to growth-induced formation of giant Hodgkin cells, fusion of small mononuclear cells followed by a size increase gives rise to giant RS cells. Of note, fusion of cells originating from the same ancestor, termed re-fusion, is seen nearly exclusively. In the majority of cases, re-fusion of daughter cells is preceded by incomplete cytokinesis, as demonstrated by microtubule bonds among the cells. We confirm at the level of individual tracked cells that giant Hodgkin and RS cells have little proliferative capacity, further supporting small mononuclear Hodgkin cells as the proliferative compartment of the HL tumor clone. In addition, sister cells show a shared propensity for re-fusion, providing evidence of early RS cell fate commitment. Thus, RS cell generation is related neither to cell fusion of unrelated Hodgkin cells nor to endomitosis, but rather is mediated by re-fusion of daughter cells that underwent mitosis. This surprising finding supports the existence of a unique mechanism for the generation of multinuclear RS cells that may have implications beyond HL, given that RS-like cells are frequently observed in several other lymphoproliferative diseases as well.

Entities:  

Mesh:

Year:  2013        PMID: 24302766      PMCID: PMC3870723          DOI: 10.1073/pnas.1312509110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.

Authors:  A van den Berg; L Visser; S Poppema
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  On some Morbid Appearances of the Absorbent Glands and Spleen.

Authors: 
Journal:  Med Chir Trans       Date:  1832

3.  Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease.

Authors:  H Kanzler; R Küppers; S Helmes; H H Wacker; A Chott; M L Hansmann; K Rajewsky
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

Review 4.  The role of cytokines in classical Hodgkin lymphoma.

Authors:  Brian F Skinnider; Tak W Mak
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

5.  Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines.

Authors:  Jun-ichiro Ikeda; Suhana Mamat; Tian Tian; Yi Wang; Nur Rahadiani; Katsuyuki Aozasa; Eiichi Morii
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

6.  Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma.

Authors:  Lara Cattaruzza; Annunziata Gloghini; Karin Olivo; Raffaele Di Francia; Debora Lorenzon; Rosaria De Filippi; Antonino Carbone; Alfonso Colombatti; Antonio Pinto; Donatella Aldinucci
Journal:  Int J Cancer       Date:  2009-09-01       Impact factor: 7.396

7.  Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles.

Authors:  H G Drexler; G Gaedicke; M S Lok; V Diehl; J Minowada
Journal:  Leuk Res       Date:  1986       Impact factor: 3.156

8.  Spindle-shaped CD163+ rosetting macrophages replace CD4+ T-cells in HIV-related classical Hodgkin lymphoma.

Authors:  Sylvia Hartmann; Christina Jakobus; Benjamin Rengstl; Claudia Döring; Sebastian Newrzela; Hans-Reinhard Brodt; Timo Wolf; Martin-Leo Hansmann
Journal:  Mod Pathol       Date:  2013-01-11       Impact factor: 7.842

9.  Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.

Authors:  Enrico Tiacci; Claudia Döring; Verena Brune; Carel J M van Noesel; Wolfram Klapper; Gunhild Mechtersheimer; Brunangelo Falini; Ralf Küppers; Martin-Leo Hansmann
Journal:  Blood       Date:  2012-09-05       Impact factor: 22.113

10.  Hodgkin's reed-sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells.

Authors:  Tsutomu Tanijiri; Toshiki Shimizu; Kazutaka Uehira; Takashi Yokoi; Hideki Amuro; Hiroyuki Sugimoto; Yoshitaro Torii; Kenichirou Tajima; Tomoki Ito; Ryuichi Amakawa; Shirou Fukuhara
Journal:  J Leukoc Biol       Date:  2007-06-01       Impact factor: 4.962

View more
  24 in total

1.  Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells.

Authors:  Marc A Weniger; Enrico Tiacci; Stefanie Schneider; Judith Arnolds; Sabrina Rüschenbaum; Janine Duppach; Marc Seifert; Claudia Döring; Martin-Leo Hansmann; Ralf Küppers
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

Review 2.  Galectins as therapeutic targets for hematological malignancies: a hopeful sweetness.

Authors:  Camilo Pena; Leonardo Mirandola; Jose A Figueroa; Nattamol Hosiriluck; Natallia Suvorava; Kayley Trotter; Adair Reidy; Rahman Rakhshanda; Drew Payne; Marjorie Jenkins; Fabio Grizzi; Lauren Littlefield; Maurizio Chiriva-Internati; Everardo Cobos
Journal:  Ann Transl Med       Date:  2014-09

3.  Tumor-infiltrating HLA-matched CD4(+) T cells retargeted against Hodgkin and Reed-Sternberg cells.

Authors:  Benjamin Rengstl; Frederike Schmid; Christian Weiser; Claudia Döring; Tim Heinrich; Kathrin Warner; Petra S A Becker; Robin Wistinghausen; Sima Kameh-Var; Eva Werling; Arne Billmeier; Christian Seidl; Sylvia Hartmann; Hinrich Abken; Ralf Küppers; Martin-Leo Hansmann; Sebastian Newrzela
Journal:  Oncoimmunology       Date:  2016-03-16       Impact factor: 8.110

4.  Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion.

Authors:  Kirsty Wienand; Bjoern Chapuy; Chip Stewart; Andrew J Dunford; David Wu; Jaegil Kim; Atanas Kamburov; Timothy R Wood; Fathima Zumla Cader; Matthew D Ducar; Aaron R Thorner; Anwesha Nag; Alexander T Heubeck; Michael J Buonopane; Robert A Redd; Kamil Bojarczuk; Lee N Lawton; Philippe Armand; Scott J Rodig; Jonathan R Fromm; Gad Getz; Margaret A Shipp
Journal:  Blood Adv       Date:  2019-12-10

Review 5.  The origins and functions of hepatic polyploidy.

Authors:  Shuyuan Zhang; Yu-Hsuan Lin; Branden Tarlow; Hao Zhu
Journal:  Cell Cycle       Date:  2019-05-26       Impact factor: 4.534

6.  Noncoding RNA Ginir functions as an oncogene by associating with centrosomal proteins.

Authors:  Suchismita Panda; Meenakshi Setia; Navjot Kaur; Varsha Shepal; Vivek Arora; Divya Kumari Singh; Abir Mondal; Abhishek Teli; Madhura Tathode; Rajendra Gajula; L C Padhy; Anjali Shiras
Journal:  PLoS Biol       Date:  2018-10-08       Impact factor: 8.029

Review 7.  Polyploid giant cancer cell characterization: New frontiers in predicting response to chemotherapy in breast cancer.

Authors:  Geetanjali Saini; Shriya Joshi; Chakravarthy Garlapati; Hongxiao Li; Jun Kong; Jayashree Krishnamurthy; Michelle D Reid; Ritu Aneja
Journal:  Semin Cancer Biol       Date:  2021-03-22       Impact factor: 17.012

8.  Reed-Sternberg cells form by abscission failure in the presence of functional Aurora B kinase.

Authors:  Ana Xavier de Carvalho; Helder Maiato; André F Maia; Susana A Ribeiro; Patrícia Pontes; Wendy Bickmore; William C Earnshaw; Clara Sambade
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

Review 9.  Pathobiology of hodgkin lymphoma.

Authors:  Claudio Agostinelli; Stefano Pileri
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-06-05       Impact factor: 2.576

10.  H2A.B is a cancer/testis factor involved in the activation of ribosome biogenesis in Hodgkin lymphoma.

Authors:  Xuanzhao Jiang; Jiayu Wen; Elizabeth Paver; Yu-Huan Wu; Gege Sun; Amanda Bullman; Jane E Dahlstrom; David J Tremethick; Tatiana A Soboleva
Journal:  EMBO Rep       Date:  2021-07-19       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.